Editorial Team


  1. Joanna Brougher, Journal of Commercial Biotechnology

Associate Editors

  1. Arlen Meyers, Professor, Department of Otolaryngology, Dentistry and Engineering, University of Colorado Denver, United States
  2. Dr. Thomas J Siepmann, Siepmann IP Consulting, PLLC

Editorial Advisory Board

  1. Mark J. Ahn, Principal, Pukana Partners, Ltd., United States
  2. Arthur Boni, John R. Thorne Distinguished Career Professor of Entrepreneurship;Tepper School of Business, Carnegie Mellon University, United States
  3. Walter Bratic, Managing Director, Overmont Consulting LLC, United States
  4. Joanna Brougher, Journal of Commercial Biotechnology
  5. Ananda Mohan Chakrabarty, University of Illinois at Chicago, United States
  6. Vijay Chandru, Chairman & CEO, Strand Life Sciences Pvt Ltd, India and Consulting Professor, ISL/EE, Stanford University, United States
  7. James Class, Director, Global Public Policy, Merck, United States
  8. Jeremy Laurence Curnock Cook, Executive Chairman, Bioscience Managers Limited, United Kingdom
  9. Iraj Daizadeh, Senior Manager, Amgen Inc, United States
  10. Mitch DeKoven, Principal, Health Economics & Outcomes Research, Real-World Evidence Solutions, IMS Health, United States
  11. Spencer G. Feldman, Partner, Olshan Frome Wolosky LLP, United States
  12. Sharon Finch, Director, Medius Associates, United Kingdom
  13. Hernan Garrido-Lecca, Chairman and CEO Bioinvest; Professor of Economics and Public Policy, Universidad de San Martín de Porres, Lima Peru and Former Minister of Health, Peru
  14. Dave Jensen, Managing Director, Kincannon & Reed Global Executive Search, United States
  15. Alan Jonason, Senior Analyst, Clearpoint Strategy Group LLC, United States
  16. Kenneth Kaitin, Director, Tufts Center for the Study of Drug Development and Professor of Medicine, Tufts University School of Medicine, United States
  17. John Khong, Owner, Niche Medical, J & M Technologies, Cell Sciences; Adjunct faculty, LKC Business School, Singapore management University, Singapore
  18. Thomas J. Kowalski, Attorney at Law, Vedder Price P.C., United States
  19. Leonard Lerer, Sudarskis & Partners, United Arab Emirates
  20. Weijun Li, Senior Research Scientist, Global Biological Development, Bayer HealthCare Pharmaceuticals, United States
  21. Bryan A. Liang, Professor of Anesthesiology & Director San Diego Center for Patient Safety, University of California San Diego School of Medicine; Professor of Law & Executive Director, Institute of Health Law Studies, California Western School of Law, United States
  22. Ken Malone, Principal, Early Charm Ventures
  23. Henry I. Miller, Senior Research Fellow of Scientific Philosophy & Public Policy, Hoover Institution, Stanford University, United States
  24. Dr. Stefan Michael Miller, Partner, Kirkland & Ellis LLP, United States
  25. Sudha Nair, Director, Global Business Development, Apotex Fermentation Inc., Canada
  26. Robin Nott, Chair of the Laws Committee, Licensing Executives Society Britain and Ireland, United Kingdom
  27. Mark Paris, Director, Bioinformatics & Molecular Biology Vaccinex, Inc.
  28. Peter Pitts, President, Center for Medicine in the Public Interest
  29. Meir Perez Pugatch, Managing Director Pugatch Consilium; Chair, Division of Health Systems Administration, School of Public Health, University of Haifa, Israel
  30. Anthony J Russo, Chairman and CEO, Russo Partners, United States
  31. Gene Rzucidlo, Partner at Hershkovitz & Associates
  32. Stephen M. Sammut, Senior Fellow, Wharton Health Care Systems and Entrepreneurial Programs and Venture Partner, Burrill & Company, United States
  33. Simon Shohet, Practice Director, Pope Woodhead & Associates Ltd, United Kingdom
  34. Grant H Skrepnek, Associate Professor, The University of Oklahoma Health Sciences Center, United States
  35. Ernest Smith, Senior Vice President of Research & Chief Scientific Officer, Vaccinex, Inc.
  36. Anthony Stevens, Director, Medical Options, United Kingdom
  37. Philip Neal Sussman, Managing Partner, The Channel Group LLC, United States
  38. Michael Weiner, CEO, Technology Innovations, United States
  39. Michael Vitale, Director of Commercialisation, Monash Asia-Pacific Centre for Science and Wealth Creation, Monash University, Australia